Beyond Air, Inc. — Director's Dealing 2019

Feb 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AIT Therapeutics, Inc. (AITB)
CIK: 0001641631
Period of Report: 2018-12-31

Reporting Person: Avniel Amir (Director, President, COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-31	Common Stock	A	45000	—	Acquired	530281	Direct
2019-01-01	Common Stock	A	12000	—	Acquired	542281	Direct

Footnotes

F1: Represents restricted stock award that vests in five equal annual installments commencing on the date of grant.